Abstract:Objective: Storage of ovarian tissue may restore long-term fertility in patients undergoing treatment that irreversibly damages oocytes. Tissue obtained before any treatment avoids chemotherapy-induced genetic abnormality. Our objective was to cryopreserve ovarian tissue, to evaluate the safety and efficacy of the procedure and to attempt to stimulate follicular growth in xenotransplanted thawed ovarian tissue.Design: Patients undergoing chemotherapy and/or radiotherapy were counseled regarding the risk of loss of ovarian function, cryostorage of ovarian cortex, transplantation into an animal host for stimulation, and ethical issues prior to enrollment. Ovarian cortex was cryopreserved, transplanted in immunosuppressed mice and stimulated with gonadotropins. Fresh, frozen and transplanted tissues were histologically evaluated.Materials and methods: Ovarian tissue was surgically removed and collected in PBS containing hFSH. The outer 4 mm of the ovarian cortex was dissected into cubes of 1×1×0.5 mm and frozen in straws or cryovials in Leibovitz medium L-15+10% serum +1.5M ethylene glycol. Fresh and frozen-thawed ovarian cortex was transplanted into nude or NOD-SCID mice, which were stimulated with hFSH.Results: 17 patients (26–39 yrs) were enrolled in this study. 12–100 ovarian fragments/patient were frozen. Follicle count decreased with patient age and a large variability in follicular number was observed between fragments, even in the same patient. Prior therapy did not preclude successful ovarian cryopreservation. The xenotransplantation of tissue from patients with good follicular counts resulted in follicular development and successful retrieval of immature oocytes.Conclusion: Oocyte retrieval from cryopreserved xenotransplanted human ovarian cortex is feasible, enabling evaluation of fertility potential as well as assessment of ovarian cryopreservation safety. Objective: Storage of ovarian tissue may restore long-term fertility in patients undergoing treatment that irreversibly damages oocytes. Tissue obtained before any treatment avoids chemotherapy-induced genetic abnormality. Our objective was to cryopreserve ovarian tissue, to evaluate the safety and efficacy of the procedure and to attempt to stimulate follicular growth in xenotransplanted thawed ovarian tissue. Design: Patients undergoing chemotherapy and/or radiotherapy were counseled regarding the risk of loss of ovarian function, cryostorage of ovarian cortex, transplantation into an animal host for stimulation, and ethical issues prior to enrollment. Ovarian cortex was cryopreserved, transplanted in immunosuppressed mice and stimulated with gonadotropins. Fresh, frozen and transplanted tissues were histologically evaluated. Materials and methods: Ovarian tissue was surgically removed and collected in PBS containing hFSH. The outer 4 mm of the ovarian cortex was dissected into cubes of 1×1×0.5 mm and frozen in straws or cryovials in Leibovitz medium L-15+10% serum +1.5M ethylene glycol. Fresh and frozen-thawed ovarian cortex was transplanted into nude or NOD-SCID mice, which were stimulated with hFSH. Results: 17 patients (26–39 yrs) were enrolled in this study. 12–100 ovarian fragments/patient were frozen. Follicle count decreased with patient age and a large variability in follicular number was observed between fragments, even in the same patient. Prior therapy did not preclude successful ovarian cryopreservation. The xenotransplantation of tissue from patients with good follicular counts resulted in follicular development and successful retrieval of immature oocytes. Conclusion: Oocyte retrieval from cryopreserved xenotransplanted human ovarian cortex is feasible, enabling evaluation of fertility potential as well as assessment of ovarian cryopreservation safety.

Cryopreservation of the Human Ovarian Tissue Induces the Expression of Fas System in Morphologically Normal Primordial Follicles.

Morphology and Cell Proliferation Evaluation of Follicles from Cryopreserved Human Ovarian Tissue by Vitrifiction and Slow-cooling

[Morphology and cell proliferation evaluation of follicles from cryopreserved human ovarian tissue by vitrification].

Influence of Programmable Freezing on Cryopreserved Effect of Human Primordial and Primary Follicles

Morphological and Apoptotic Comparison of Primordial and Primary Follicles in Cryopreserved Human Ovarian Tissue.

Effect of Ovarian Tissue Cryopreservation on Gene Expression and Growth of Human Individual Follicle in Vitro

Effects of different freezing methods on the follicular viability of large pieces of human ovarian tissues

Research of Two Methods for Human Ovarian Tissues Cryopreservation

Human single follicle growth in vitro from cryopreserved ovarian tissue after slow freezing or vitrification

Cryopreservation of Human Ovarian Tissue and It's Evaluation

The Increased Expression of Connexin and VEGF in Mouse Ovarian Tissue Vitrification by Follicle Stimulating Hormone

Modified Vitrification Method for Cryopreservation of Human Ovarian Tissues

Vascular endothelial growth factor expression and angiogenesis in human ovarian tissue after different cryopreservations

Comparative investigation on the effects of different cryoprotectants on morphology of frozen-thawed human ovarian tissue

Effects of Cryopreservation on Mouse Ovarian Tissue after Vitrification

Vitrification freezing of large ovarian tissue in the human body

Human Ovarian Cortex Cryopreservation and Banking

The Revascularization and Follicular Survival of Mouse Ovarian Grafts Treated with FSH During Cryopreservation by Vitrification.

Exogenous Luteinizing Hormone Promotes Ovarian Survival and Function During Cryopreservation and Transplantation

Expression of the Caspase-3, TNF-α, bcl-2 and bax in the fetal ovarian

Assessment of ovarian tissue and follicular integrity after cryopreservation via slow freezing or vitrification followed by in vitro culture